background fluorescence (SouthernBiotech)
Structured Review
Background Fluorescence, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 96/100, based on 4648 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/background+fluorescence/DAPI+Fluoromount-G/pm38912583-128-14-23
Average 96 stars, based on 4648 article reviews
Images
Related Articles
Incubation:Article Title: Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD Article Snippet: Sections were incubated with rabbit anti–mouse Ki-67 (1:200; ab15580, Abcam) overnight at 4°C, followed by incubation with Cy3-conjugated donkey anti-rabbit IgG (1:200; 711-165-152 Jackson Immunoresearch) and fluorescein-labeled Dolichos biflorus agglutinin (DBA) (1:200; FL-1031, Vector Laboratories) for 2 hours at room temperature. .. Sections were then incubated in 0.1% Sudan black B in 70% ethanol to reduce Article Title: Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD. Article Snippet: Sections were incubated with rabbit anti–mouse Ki-67 (1:200; ab15580, Abcam) overnight at 4°C, followed by incubation with Cy3-conjugated donkey anti-rabbit IgG (1:200; 711-165-152 Jackson Immunoresearch) and fluorescein-labeled Dolichos biflorus agglutinin (DBA) (1:200; FL-1031, Vector Laboratories) for 2 hours at room temperature. .. Sections were then incubated in 0.1% Sudan black B in 70% ethanol to reduce Fluorescence:Article Title: Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD Article Snippet: Sections were incubated with rabbit anti–mouse Ki-67 (1:200; ab15580, Abcam) overnight at 4°C, followed by incubation with Cy3-conjugated donkey anti-rabbit IgG (1:200; 711-165-152 Jackson Immunoresearch) and fluorescein-labeled Dolichos biflorus agglutinin (DBA) (1:200; FL-1031, Vector Laboratories) for 2 hours at room temperature. .. Sections were then incubated in 0.1% Sudan black B in 70% ethanol to reduce Article Title: Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD. Article Snippet: Sections were incubated with rabbit anti–mouse Ki-67 (1:200; ab15580, Abcam) overnight at 4°C, followed by incubation with Cy3-conjugated donkey anti-rabbit IgG (1:200; 711-165-152 Jackson Immunoresearch) and fluorescein-labeled Dolichos biflorus agglutinin (DBA) (1:200; FL-1031, Vector Laboratories) for 2 hours at room temperature. .. Sections were then incubated in 0.1% Sudan black B in 70% ethanol to reduce |
![A p14 ARF structural features, including PSI-PRED4.0 secondary structure prediction (2 o Struc.), CIDER linear net charge per residue (LNCPR) and linear hydropathy (Hydro.). The CIDER analysis for p14 ARF ΔH1-3 is shown below. B Zoomed in regions from confocal <t>fluorescence</t> micrographs of NPM1-AF488 in condensates with p14 ARF (top) and p14 ARF ΔH1-3 (bottom). Scale bars = 10 µm. C Index of dispersion for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace; derived from n = 6, 6, 6, 7, 6, 6, 7, 6, 6, 6, 7 images) and p14 ARF ΔH1-3 (blue boxes and whiskers and trace, where n = 5, 4, 6, 6, 8, 6, 6, 6, 6, 6, 6 images). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The black arrow highlights the increased NPM1 saturation concentration, ΔC sat , upon substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues. The gray arrow highlights the reentrant phase transition, which occurs at elevated p14 ARF concentrations. D ΔG tr for NPM1 in condensates with p14 ARF (gray boxes, whiskers and trace, where n = 696, 42, 61, 159, 225, 285, 333, 276, 306, 227, 773 condensates) and p14 ARF ΔH1-3 (blue boxes, whiskers and trace, where n = 2561, 1787, 29, 31, 82, 92, 134, 153, 166, 145, 162 condensates). Whiskers extend from the box to the furthest point within 1.5x the inter-quartile range. The C sat for NPM1 increases when p14 ARF hydrophobic residues are substituted. The gray arrow highlights the destabilization of NPM1 during the reentrant phase transition. E CV-SANS curves for p14 ARF ΔH1-3-[ 2 H]-NPM1 condensates collected at 50% D 2 O, where p14 ARF ΔH1-3 is contrast matched ([ 2 H]-NPM1 detected; green trace), at 85% D 2 O where [ 2 H]-NPM1 is contrast matched (p14 ARF ΔH1-3 detected; blue trace), and p14 ARF ΔH1-3-NPM1 condensate at 100% D 2 O for full scattering intensity (NPM1 and p14 ARF ΔH1-3 detected; gray trace). All curves are offset for clarity. Scatter points represent the average, the error bars represent the uncertainty derived from the counting statistics of the SANS instrument, as described and cited in the Methods. F Schematic describing condensed NPM1 with extended IDR conformations. G Schematic describing condensed p14 ARF ΔH1-3 in an extended conformation. H FRAP of NPM1-AF488 within condensates shows that substitution of p14 ARF hydrophobic residues to Gly/Ser spacer residues restores NPM1 mobility. Scale bars = 1 µm. I FRAP recovery curves for p14 ARF -NPM1 and p14 ARF ΔH1-3-NPM1 condensates with fits, as described in Methods (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 curves for each condition, the p -value is shown in the figure). J NPM1-AF488 D App values extracted from the FRAP recovery curves in panel I (statistical significance was assessed by two-sided Wilcoxon rank-sum test, n = 10 D App values for each condition, the p -value is shown in the figure).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_5371/pmc11555371/pmc11555371__41467_2024_53904_Fig4_HTML.jpg)